4.7 Article

Reversal of Lipid Metabolism Dysregulation by Selenium and Folic Acid Co-Supplementation to Mitigate Pathology in Alzheimer's Disease

Journal

ANTIOXIDANTS
Volume 11, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/antiox11050829

Keywords

selenium; folate; selenoprotein; Alzheimer's disease; lipid metabolism; homocysteine

Funding

  1. National Natural Sciences Foundation of China [31800681, 32171223]
  2. Guangdong Natural Science Foundation [2021A1515010557]
  3. Shenzhen Fundamental Research Program [JCYJ20200109105836705]
  4. Guangdong Natural Science Foundation for Major Cultivation Project [2018B030336001]
  5. Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions [2019SHIBS0003]

Ask authors/readers for more resources

This study demonstrates the therapeutic potential of combined supplementation of selenium and folic acid in Alzheimer's disease. The treatment regimen improves synaptic plasticity and cognitive ability by modulating brain lipid metabolism, potentially through antioxidant effects and promoting homocysteine metabolism.
Aberrant lipid metabolism is reported to be closely related to the pathogenesis of neurodegenerative diseases, such as Alzheimer's disease (AD). Selenium (Se) and folate are two ideal and safe nutritional supplements, whose biological effects include regulating redox and homocysteine (Hcy) homeostasis in vivo. Here, to achieve effective multitarget therapy for AD, we combined Se and folic acid in a co-supplementation regimen (Se-FA) to study the therapeutic potential and exact mechanism in two transgenic mouse models of AD (APP/Tau/PSEN and APP/PS1). In addition to a reduction in A beta generation and tau hyperphosphorylation, a restoration of synaptic plasticity and cognitive ability was observed in AD mice upon Se-FA administration. Importantly, by using untargeted metabolomics, we found that these improvements were dependent on the modulation of brain lipid metabolism, which may be associated with an antioxidant effect and the promotion of Hcy metabolism. Thus, from mechanism to effects, this study systematically investigated Se-FA as an intervention for AD, providing important mechanistic insights to inform its potential use in clinical trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available